Form 4 for NEPH NEPHROS INC
Accepted 2021-08-23 00:00:00 ET · period of report 2021-08-20 · accession 0000914190-21-000286 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-23 | 2021-08-20 | NEPH | Lobo Wesley S. | CMO | P - Purchase | $7.92 | +1,000 | 41.6K | +2% | +$7,920 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-20 | P | A | 1,000 | $7.92 | 41,557 | D | — | — | (F1) Includes (i) 20,557 shares of restricted stock for which the risk of forfeiture will lapse on 2/16/22; and (ii) 20,000 shares of restricted stock for which the risk of forfeiture will lapse as to 5,000 shares on each of 2/16/22, 2/16/23, 2/16/24 and 2/16/25. |